Le Lézard
Classified in: Health, Science and technology, Business
Subject: BOARD OF DIRECTORS

Aptose Announces Appointment of Caroline M. Loewy to Board of Directors


SAN DIEGO and TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today announced the appointment of Caroline M. Loewy to the Board of Directors effective immediately. Aptose's Board of Directors now includes seven members with extensive experience across diverse disciplines in biotechnology and pharmaceutical development.

Ms. Loewy is an accomplished executive leader with more than 25 years of experience in accelerating biotechnology product development and growth.  She currently provides strategic advisory services to life science companies on a variety of high-impact matters including funding strategies, product pipeline evaluation, and assessing business development opportunities. Ms. Loewy has held numerous executive roles; most recently, she co-founded and served as Chief Financial Officer and Chief Business Officer of Achieve Life Sciences, Inc. Prior to that, she held the position of Chief Financial Officer of both public and private biopharmaceutical companies including Tobira Therapeutics, Inc., Corcept Therapeutics Incorporated, and Poniard Pharmaceuticals, Inc. Ms. Loewy also spent 11 years as a senior biotechnology equity research analyst at Morgan Stanley and Prudential Securities. She sits on the board of directors of CymaBay Therapeutics Inc.; is a founding board member of the Global Genes Project, one of the leading rare disease patient advocacy organizations in the world; and is a member of the National Advisory Council of the Translational Genomics Research Institute (TGen) Center for Rare Childhood Disorders. Ms. Loewy is also a founding board member of the KCNQ2 Cure Alliance Foundation. Ms. Loewy holds a BA degree from the University of California, Berkeley, and an MBA/MS degree from Carnegie Mellon University.

"With her years of experience as a respected executive leader in our industry, Caroline Loewy considerably strengthens our board's breadth of talent and background," said William G. Rice, Ph.D., Chairman, President and Chief Executive Officer.  "We very much look forward to working with her and drawing upon her strategic judgment."

"I am excited to join the Board at a pivotal time in the company's evolution," said Caroline Loewy. "I look forward to working with the team at Aptose to help advance the development of novel anti-cancer therapies."

About Aptose

Aptose Biosciences is a clinical-stage biotechnology company committed to developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities. For further information, please visit www.aptose.com.

For further information, please contact:

Aptose Biosciences
Greg Chow, CFO
647-479-9828
[email protected] 
  
   
SMP Communications
Susan Pietropaolo
201-923-2049
[email protected]
 LifeSci Advisors
Michael Wood
Managing Director
646-597-6983
[email protected] 

These press releases may also interest you

at 10:12
NerdsToGo®, a leading information technology (IT) solutions and technology repair services franchise for both business and home, announced today plans for its strategic expansion throughout the greater Chicago area with 20 new territories available...

at 10:10
The group division of Ameritas proudly announces its 17th consecutive certification as a BenchmarkPortal Center of Excellence, solidifying its position as a leader in customer service and support excellence. This prestigious recognition for 2023...

at 10:00
Frost & Sullivan recently researched the customer experience outsourcing services industry and, based on its findings, recognizes AeC with the 2023 Company of the Year Award. AeC is connecting technology with outstanding customer service to increase...

at 10:00
Seniors Helping Seniors® in-home care services, a franchisor with over 125 franchise partners and more than 200 territories nationwide, has grown rapidly in recent years by building a workforce of talented caregivers who create meaningful...

at 10:00
PKF Clear Thinking, the award-winning business advisory firm and subsidiary of PKF O'Connor Davies, one of the nation's largest accounting, tax and advisory practices, is proud to announce that it has been awarded the "Section 363 Sale of the Year...

at 10:00
PLACE, the industry's only all-in-one platform for top teams at any brokerage, has announced that Spring Bengtzen and Utah Life Real Estate Group are now powered by PLACE. PLACE improves profitability and production to make running a real estate...



News published on and distributed by: